These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17174104)

  • 1. Modeling non-random deletions in cancer.
    Kost-Alimova M; Imreh S
    Semin Cancer Biol; 2007 Feb; 17(1):19-30. PubMed ID: 17174104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionarily plastic regions at human 3p21.3 coincide with tumor breakpoints identified by the "elimination test".
    Darai E; Kost-Alimova M; Kiss H; Kansoul H; Klein G; Imreh S
    Genomics; 2005 Jul; 86(1):1-12. PubMed ID: 15913951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer.
    Kholodnyuk ID; Kost-Alimova M; Yang Y; Kiss H; Fedorova L; Klein G; Imreh S
    Genes Chromosomes Cancer; 2002 Jul; 34(3):341-4. PubMed ID: 12007195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors.
    Yang Y; Kiss H; Kost-Alimova M; Kedra D; Fransson I; Seroussi E; Li J; Szeles A; Kholodnyuk I; Imreh MP; Fodor K; Hadlaczky G; Klein G; Dumanski JP; Imreh S
    Genomics; 1999 Dec; 62(2):147-55. PubMed ID: 10610706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.
    Kost-Alimova M; Kiss H; Fedorova L; Yang Y; Dumanski JP; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6622-7. PubMed ID: 12738884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
    Angeloni D
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3.
    Kiss H; Yang Y; Kiss C; Andersson K; Klein G; Imreh S; Dumanski JP
    Eur J Hum Genet; 2002 Jan; 10(1):52-61. PubMed ID: 11896456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM.
    Szeles A; Yang Y; Sandlund AM; Kholodnyuk I; Kiss H; Kost-Alimova M; Zabarovsky ER; Stanbridge E; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Dec; 20(4):329-36. PubMed ID: 9408748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.
    Hoebeeck J; Michels E; Menten B; Van Roy N; Eggert A; Schramm A; De Preter K; Yigit N; De Smet E; De Paepe A; Laureys G; Vandesompele J; Speleman F
    Int J Cancer; 2007 Feb; 120(3):533-8. PubMed ID: 17096344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of lung tumor suppressor activity at 3p21.3.
    ter Elst A; Hiemstra BE; van der Vlies P; Kamminga W; van der Veen AY; Davelaar I; Terpstra P; te Meerman GJ; Gerbens F; Kok K; Buys CH
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1077-93. PubMed ID: 16958100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors].
    Braga EA; Kiselev LL; Zabarovskiĭ ER
    Mol Biol (Mosk); 2004; 38(2):179-90. PubMed ID: 15125222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.
    Kok K; Naylor SL; Buys CH
    Adv Cancer Res; 1997; 71():27-92. PubMed ID: 9111863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
    McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
    Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice.
    Kholodnyuk ID; Kozireva S; Kost-Alimova M; Kashuba V; Klein G; Imreh S
    Int J Cancer; 2006 Jul; 119(1):99-107. PubMed ID: 16432833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
    Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular senescence bypass screen identifies new putative tumor suppressor genes.
    Leal JF; Fominaya J; Cascón A; Guijarro MV; Blanco-Aparicio C; Lleonart M; Castro ME; Ramon Y Cajal S; Robledo M; Beach DH; Carnero A
    Oncogene; 2008 Mar; 27(14):1961-70. PubMed ID: 17968325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.